Common differentiating agents facilitate transcriptional reprogramming by bromodomain inhibition
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54548
下载链接
链接失效反馈官方服务：
资源简介：
Dimethyl sulfoxide (DMSO) and hexamethylene bisacetamide (HMBA) are biologically active molecules that have shown clinical efficacy in cancer and inflammation, though their therapeutic application has been limited, partly because their mechanism of action is unknown. We demonstrate that DMSO and HMBA facilitate rapid transcriptional reprogramming via competitive inhibition of bromodomain-containing proteins. These results identify novel therapeutic avenues and provide context to over 50 years of biomedical research with these agents. HL60 treated with differentiating agents
创建时间：
2019-02-18
